Position in NVS
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$2,075,442
+$277,728 QoQ
Shares Held
13,243
+12.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#418
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. NVS ranks #9 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,075,442 | 13,243 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $1,797,714 | 11,769 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,100,340 | 7,981 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $980,394 | 7,645 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $898,136 | 7,422 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $810,682 | 7,272 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $724,959 | 7,450 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $882,663 | 7,674 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $891,708 | 8,376 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $875,019 | 9,046 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $861,173 | 8,529 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $912,156 | 8,955 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $824,232 | 8,168 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $652,372 | 7,091 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $697,908 | 7,693 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $570,911 | 7,511 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $648,852 | 7,676 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $509,388 | 5,805 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $676,930 | 7,739 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $659,964 | 8,070 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $707,931 | 7,759 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $591,436 | 6,919 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $581,405 | 6,157 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $553,848 | 6,369 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $655,050 | 7,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $970,106 | 11,766 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||